Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00286611 · ClinicalTrials.gov registry record
Determination of Amifostine Levels During Radiation Therapy
A clinical trial, sponsored by University of Iowa.
- Completed
- Registry status
- 13
- Enrollment target
NCT00286611 is a clinical trial that has completed, run by University of Iowa. The registered enrollment target is 13 participants.
The verdict
NCT00286611 has completed, sponsored by University of Iowa.
- COMPLETED
- Registry status
- 13 participants
- Enrollment target
Study Summary
Currently, there are no published methods for easily determining the level of amifostine in the blood or saliva. A method has been developed within the Department of Radiation Oncology by Drs. Douglas Spitz and Gurminder Sidhu, within the Spitz Lab. This method has been tested using both animal sampling and expired blood (obtained from DeGowin blood center) mixed with amifostine. If the method proves successful, it could then be used as a tool to quantify blood and salivary amifostine levels and possibly correlate them to treatment efficacy or limiting adverse events using amifostine. A better method of treatment, either increasing the efficacy of amifostine or reducing its unwanted side effects, could then be developed.
Interventions
- PROCEDURE Blood and salivary sampling of amifostine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2004-10 |
| Est. Completion | 2008-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00286611
The ClinicalTrials.gov registry entry for NCT00286611 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Iowa, which has 228 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Blood and salivary sampling of amifostine is the first listed.
NCT00286611 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00286611 about?
NCT00286611 is a clinical study titled "Determination of Amifostine Levels During Radiation Therapy". Currently, there are no published methods for easily determining the level of amifostine in the blood or saliva. A method has been developed within the Department of Radiation Oncology by Drs. Douglas Spitz and Gurminder Sidhu, within the Spitz Lab. This method has been tested using both animal samp...
What is the current status of trial NCT00286611?
This trial is currently completed. The enrollment target is 13 participants. The study started on 2004-10. Estimated completion is 2008-05.
What interventions are being tested in trial NCT00286611?
The interventions under investigation include: Blood and salivary sampling of amifostine (PROCEDURE).
Who is sponsoring clinical trial NCT00286611?
This trial is sponsored by University of Iowa, which has 228 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.